US biotech giant Amgen announced plans to open a new technology and innovation site in Hyderabad, India. The site will be located in HITEC City and will occupy six floors of the RMZ Spire Tower. It is expected to be operational in Q4 2024 and has the potential to accommodate up to 3,000 people.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/dRoODCN
via IFTTT
-
Vaccine manufacturer Serum Institute of India (SSI) has filed a challenge to the Supreme Court against a 2016 amendment to the Income Tax Ac...
-
Kotak Alternate Asset Managers has announced a Rs 1,445 crore investment in the acquisition of Viatris' active pharmaceutical ingredient...
-
Acquista ********, Ossicodone, Ketamina, Ozempic (WhatsApp: +31616337954) I nostri prodotti hanno una purezza del 98-99%. E-mail di cont...
Search This Blog
Powered by Blogger.
Blog Archive
-
▼
2024
(774)
-
▼
August
(77)
- PCOS on the rise in young women: Are you at risk?
- Sooji breakfast recipes: 5 healthy and easy option...
- Zydus Lifesciences gets warning letter from USFDA ...
- Zydus Lifesciences gets USFDA nod to market Scopol...
- 7 protein-packed dinners for healthy weight loss
- Monkeypox RT-PCR Test: A step-by-step guide for ac...
- Listeria infection: Symptoms, source, and prevention
- Want to purify your blood? Try these 6 foods
- Biocon settles with Janssen to commercialise biosi...
- Indian pharma exporters feel pain on Bangladesh cr...
- Hillhouse bids highest to buy healthcare BPO GeBBS...
- Sloth fever outbreak: Key facts on the deadly viru...
- Fairfax, Bain look to buy Gujarat's API Company Fa...
- Bharat Biotech launches oral cholera vaccine Hillc...
- India develops indigenous Monkeypox RT-PCR testing...
- More fixed-dose combo drugs may enter ban list
- Alembic Pharma gets USFDA nod for generic drug
- TB testing technology developed by ICMR's regional...
- Pharma companies seek more time to implement revis...
- India aims to lead next industrial revolution with...
- Danfoss India confident of doubling sales by 2025,...
- USFDA pulls up Eugia for manufacturing lapses, dat...
- Revoke 18% GST on health and life insurance premiu...
- Zydus Lifesciences acquires 50% stake in Sterling ...
- Zydus Lifesciences to acquire 50 pc stake in Sterl...
- How to reduce belly fat without exercise
- Govt bans 156 fixed-dose combo drugs over risks
- B'desh upheaval takes a toll on medical tourism in...
- ICMR-led study estimates 10-year risk of developin...
- Struggling with monsoon joint pain? These foods ca...
- Alkem arm ties up with Exactech for knee, hip repl...
- USFDA flags Telangana unit of Aurobindo Pharma arm
- Scheme to bolster medical device industry to roll ...
- Indoco Remedies gets USFDA nod to market Lofexidin...
- Mpox vaccine coming soon, says Covishield manufact...
- Ipca Labs expects its US generics sales to touch $...
- Serum Institute says working to develop Monkeypox ...
- Bloated every morning? Try these home remedies for...
- Granules India gets USFDA nod for generic Glycopyr...
- Operation buyout: KKR, TPG, and other PE firms eye...
- Health ministry approves 25% enhancement in securi...
- Aurobindo Pharma to commercialise China plant in t...
- Indian govt needs to trim citizens' waist size for...
- PM Modi monitoring Mpox status; meeting takes stoc...
- Baba Ramdev criticises 'toxic' allopathy medicines...
- Pharma Department discusses 'dumping' with glovema...
- Ipca launches new topical therapy against diabetic...
- Domestic pharmaceutical retail market grows 11 per...
- Aurobindo Pharma's Eugia Unit-3 gets warning lette...
- AstraZeneca gets $107 mln Pfizer verdict overturne...
- Aurobindo may take its injectable unit public
- Nishkala Healthcare acquires Navi Mumbai's Suasth ...
- Alembic gets USFDA nod for generic medication
- Southern states witness majority heart transplants...
- Biocon arm's growth formula: US rollouts & debt re...
- SSUHS signs MoU with Novo Nordisk Foundation
- Revenue of domestic API firms to see 7-8 pc increa...
- Dr Reddy's gets establishment inspection report fr...
- As monsoon takes hold, anti-infective, respiratory...
- What not to drink: 7 beverages that can worsen fat...
- At over 10 cr, India’s diabetic population is surg...
- Explore lesser-known Indian nuts: Chilgoza, Chirau...
- Hospital chain Medanta lines up Rs 1,200 crore for...
- Boost kidney health with these 7 detoxifying foods
- India eases drug approval process, waives local tr...
- Biotech giant Amgen plans to open to technology & ...
- Fortis Healthcare to buy out PE funds from diagnos...
- Bajaj could make a difference in healthcare space
- India waives clinical trial requirement for drugs ...
- India's Fortis Healthcare chairman Ravi Rajagopal ...
- BHU study on Covaxin had serious methodological fl...
- Pharma industry urges govt for stable drug pricing...
- Hamara Hospital! Bajaj plans a healthcare ride
- New data reveals why patients from the US and UK a...
- Sun Pharma's hair loss drug in the cross hairs in US
- Bharat Biotech credited ICMR, NIV as Covaxin co-in...
- Sanofi gets drug regulator nod to market RSV thera...
-
▼
August
(77)
Recent Posts
Unordered List
Theme Support
-
Text Widget
Design by FlexiThemes | Blogger Theme by Lasantha - PremiumBloggerTemplates.com | Best Gadgets | Distributed By Gooyaabi Templates
0 comments:
Post a Comment